The knockdown of COPB2 in gastric cancer cell lines suppressed colony formation and promoted apoptosis via the inhibition of RTK signaling and downstream signaling cascade molecules, which suggests that COPB2 is a potential target for gene silencing for the treatment of gastric cancer [14]. This evidence concerns the gene COPB2 and gastric cancer.